This Cancer Survivor Was Kicked Off Hospice: Learn How CHIPSA Hospital Helped Her Heal
Patients on end-of-life care are usually just making themselves comfortable, but Stacy W. was doing exactly the opposite. Unwilling to give up on her life, Stacy continued to pursue a natural path towards healing. It wasn’t long before she was kicked off hospice and told her cancer was completely gone. Learn how Stacy went from […]
Continue readingIntegrative Oncology: How CHIPSA Hospital’s Approach is the Future of Cancer Treatment
The United States has certainly come a long way in the last few decades in its ability to successfully treat cancer. Yet still, so many people have died from the disease, creating a growing frustration over the lack of treatment options. Many standard of care protocols have been the same for over 30 years, with […]
Continue readingCHIPSA and North Beach Clinic Launch new Coley’s CPG Treatment (Exclusive)
The U.S. Food and Drug Administration (FDA) currently has several ongoing trials testing immunotherapy cancer treatments like CPG and checkpoint inhibitor drugs. In fact, the internet was up in arms last year when Stanford University doctors cured 87 out of 90 mice with a “vaccine” that stimulated the immune system to attack cancerous cells. It […]
Continue readingWhat Makes This Gerson Cancer Treatment Different at CHIPSA?
The history of CHIPSA Hospital is in a way, the history of Gerson Therapy itself. We are known as the Gerson Therapy hospital because our hospital was founded by Charlotte Gerson, the daughter of Max Gerson, the man who created the Gerson Immuno-Nutrition Protocol. The hospital that is now CHIPSA began using the Gerson Protocols […]
Continue readingCancer Patient’s 10-Centimeter Tumor Fades Away After Going To CHIPSA In Mexico!
John D. was diagnosed with stage 4 squamous cell and basal cell carcinoma in his neck over three years ago. Last year, John had developed a fluid-filled sac on his neck that began to change, harden, and grow. The growth eventually spread throughout his throat all the way to the other side of his neck. Having […]
Continue readingHow Russell W. Beat Terminal Lymphoma at CHIPSA Hospital!
Russell W. was given 6 months to live back in 2018 after his non-Hodgkin’s lymphoma spread to his skin. But now, nearly 14 months later, he is alive, well, and eager to share his story. Russell’s journey began when he noticed a swollen lymph node near his elbow back in 2016. […]
Continue readingResearch Team Discovers New Immune “Checkpoint” Protein
A recent report in the journal Cell showed that a team led by Vanderbilt researchers has found a new “checkpoint” protein on immune system cells in active, malignant tumors. In mouse models, blocking this protein, along with using other treatments, has been an effective approach to treating cancerous cells. Checkpoint proteins are an important component of […]
Continue readingStudy Shows Better Immunotherapy Outcomes in Tumors with More Mutations
A recent study published in Nature Genetics called “Tumor mutational load predicts survival after immunotherapy across multiple cancer types” revealed that tumors with more mutations had better results with immunotherapy treatment. The study looked at data from 1,662 metastatic cancer patients who received checkpoint inhibitor therapy, and data from over 5,000 patients who were not treated […]
Continue readingResearchers Use AI to Improve Immunotherapy Outcomes
A research team from the University of Maryland is utilizing artificial intelligence (AI) to determine the most effective ways to treat cancer patients with immunotherapy. Immunotherapy takes advantage of the body’s own immune system to fight off cancer, and in the past decade, it has been very successful in treating patients with localized and advanced […]
Continue readingPhase 3 Trial Tests Tyvyt as Esophageal Cancer Therapy
The ORIENT-15 Phase 3 clinical trial evaluating Tyvyt (sintilimab injection) combined with chemotherapies Taxol (paclitaxel) and Platinol (cisplatin) as treatment for esophageal squamous cell carcinoma is now underway. Tyvyt was developed by Innovent Biologics and Eli Lilly and Company in China as an immune checkpoint inhibitor that will work against PD-1, a protein found on […]
Continue reading